Delivery Order SPE2DR25D3803-SPE2DR26F6ZDE

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, valued at $1,312.94. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The award is issued as a child contract under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs.

This delivery order exemplifies the routine pharmaceutical supply operations facilitated through AmerisourceBergen's prime vendor contract with DLA. The company's federal contract portfolio demonstrates extensive capability in delivering a broad spectrum of medications and medical supplies across multiple therapeutic domains, including diabetes management products, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. As a primary pharmaceutical provider for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen's competitively awarded contracts—ranging from small transactions to orders exceeding $45,000—reflect its established position as a key distributor supporting military medical supply chains on a global scale.